澳大利亚的CRISPR基因组编辑专利格局
Naomi Foo1, Olumayowa Adesanya2, Jane Nielsen3
1Research Assistant.
Journal of law and medicine
|February 2, 2024
概括
澳大利亚研究人员在健康方面表现出色,但在产品创新方面落后. 一项关于CRISPR基因组编辑专利的研究揭示了澳大利亚的最小贡献,突出了当地创新者在这个领域面临的挑战.
科学领域:
- 生物技术和基因工程 生物技术和基因工程
- 知识产权法 知识产权法 知识产权法
- 健康和医学研究商业化 商业化
背景情况:
- 澳大利亚在健康和医学研究方面拥有悠久的历史.
- 国家创新通常以专利申请来衡量,这是澳大利亚创新者表现出有限成功的领域.
- 该研究调查了特定的技术领域,以确定澳大利亚创新的潜在口袋.
研究的目的:
- 评估澳大利亚研究人员对创新的贡献,以专利申请为指标.
- 采用聚类正规间隔短平行体重复 (CRISPR) 基因组编辑作为创新分析的案例研究.
- 确定澳大利亚创新者是否在特定技术领域做出重大贡献.
主要方法:
- 分析与聚类正规间隔短平行体重复 (CRISPR) 基因组编辑技术相关的专利申请.
- 基于一般方法,成分和特定疾病应用的专利分类.
- 澳大利亚申请人在全球专利领域的贡献量化.
主要成果:
- 基因组编辑CRISPR专利领域非常广泛,涵盖了各种应用.
- 澳大利亚申请人占了很小的一小部分,在519份申请中只有4份.
- 这表明澳大利亚在CRISPR创新中的存在有限.
结论:
- 澳大利亚的创新者在复杂的CRISPR专利领域面临重大挑战.
- 对澳大利亚实体来说,确保在这个领域运营的自由可能是困难的.
- 需要进一步的战略来支持澳大利亚的创新和对新兴生物技术的专利.
关键词:
澳大利亚 澳大利亚 澳大利亚克里斯普尔是什么意思?克里斯普尔是什么意思?基因组编辑 基因组编辑patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent申请专利 申请专利专利景观设计 专利景观设计相关概念视频
CRISPR and crRNAs
17.0K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.0K
CRISPR
51.0K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
51.0K
Homologous Recombination
50.5K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.5K
What is Genetic Engineering?
74.1K
Overview
74.1K


